Saxena Anjani, Tamuly Shantanu, Saxena M K
Animal Biotechnology Center, Department of Veterinary Physiology and Biochemistry, G.B.P.U.A and T, Pantnagar, Uttarakhand, India.
J Nat Sci Biol Med. 2012 Jul;3(2):133-8. doi: 10.4103/0976-9668.101885.
Typhoid is one of the most important diseases of human beings caused by Salmonella Typhi. There are many vaccine reported against Salmonella Typhi, but search for new candidate vaccine antigens is still going on because presently available vaccines have several limitations such as short-term immunity, high cost, and allergic reaction. Several approaches such as subunit vaccines, Vi polysaccharide, mutant vaccines, and r-DNA vaccines have been tested. r- DNA vaccines have shown some promising potential (targeted Omp). Omp 28 had shown very promising results and suggests that it should be used in further studies of animal protection against the disease.
Cloning, Sequencing and In silico analysis of Omp 28 gene to develop r-DNA vaccine of S. Typhi.
Omp 28 is made up of three identical subunits of 9.6 kDa showing PCR amplicon of 330 bp which has been cloned in the pJET vector. Recombinant clones has been sequenced, and data submitted to NCBI. Secondary structure was deduced by the Chou Fasman and Garnier method. The sequence of Omp 28 was studied for antigenic indexing, epitope mapping, and MHC mapping using various bioinformatics tool.
The sequence of Omp 28 has been assigned accession no GQ 907044.1 by NCBI. Secondary structure has shown it has more alpha region. Hydrophobic plot and surface probability plot shows most amino acids are surface exposed which is a requirement to develop a r-DNA vaccine. Antigenic sites are located within surface exposed regions and eight antigenic determinants are present in Omp 28. On Prosite analysis of Protein shown two motifs i.e. anaphylatoxin domain signature motif at position 219-252 and other one was iron sulphur binding region signature motif at position 36-44. On epitope analysis total six major B cell epitopes were observed which can provoke humoral immunity. On T cell epitope mapping several major epitopes has been found in case of MHC class I and MHC class II. It indicates that Omp 28 can provoke cell mediated as well as humoral immunity and can be proven a promising candidates of Salmonella Typhi.
伤寒是由伤寒沙门氏菌引起的人类最重要的疾病之一。有许多针对伤寒沙门氏菌的疫苗被报道,但寻找新的候选疫苗抗原的工作仍在继续,因为目前可用的疫苗存在一些局限性,如短期免疫、高成本和过敏反应。已经测试了几种方法,如亚单位疫苗、Vi多糖疫苗、突变疫苗和重组DNA疫苗。重组DNA疫苗已显示出一些有前景的潜力(靶向外膜蛋白)。外膜蛋白28已显示出非常有前景的结果,并表明它应在动物抗该疾病保护的进一步研究中使用。
对Omp 28基因进行克隆、测序和计算机分析,以开发伤寒沙门氏菌的重组DNA疫苗。
Omp 28由三个9.6 kDa的相同亚基组成,显示出330 bp的PCR扩增片段,该片段已克隆到pJET载体中。对重组克隆进行了测序,并将数据提交给NCBI。通过Chou Fasman和Garnier方法推导二级结构。使用各种生物信息学工具对Omp 28的序列进行抗原索引、表位作图和MHC作图研究。
Omp 28的序列已被NCBI赋予登录号GQ 907044.1。二级结构显示它有更多的α区域。疏水图和表面概率图显示大多数氨基酸位于表面暴露区域,这是开发重组DNA疫苗的一个要求。抗原位点位于表面暴露区域内,Omp 28中有八个抗原决定簇。对蛋白质进行Prosite分析显示有两个基序,即219 - 252位的过敏毒素结构域特征基序和36 - 44位的铁硫结合区域特征基序。在表位分析中,共观察到六个主要的B细胞表位,可激发体液免疫。在T细胞表位作图中,在MHC I类和MHC II类情况下发现了几个主要表位。这表明Omp 28可激发细胞介导免疫和体液免疫,可被证明是伤寒沙门氏菌的一个有前景的候选疫苗。